Govt Job for M.Pharm, M.Sc under Dept of Science and Technology

Jamia Hamdard was conceived as a seat of higher learning in Unani Medicine, Islamic Studies, Biosciences, Pharmacy, Nursing and other areas of knowledge by its founder as a means of fulfilling the objects of the wakf.

Over a period of last ten years, Jamia Hamdard has emerged as an outstanding institution of higher learning with distinct and focused academic programmes.

Graduate programme in Information Technology and Computer Applications and Post-graduate programmes in Information Technology, Computer Applications, Business Management, Physiotherapy and Occupational Therapy have been started in the last few years.

ADVERTISEMENT FOR JUNIOR RESEARCH FELLOW IN THE RESEARCH PROJECT SPONSORED BY SERB, DEPARTMENT OF SCIENCE & TECHNOLOGY, GOVT. OF INDIA

Tile of Project: “Cognitive remediation through Behavioral Reinforcement in Traumatic Brain Injury”

Essential qualifications :

M.Sc. Toxicology or M.Pharm. (Pharmacology) with first division
Qualified NET – JRF/LS examination of CSIR/UGC/ICMR for M.Sc. applicants or GATE for M.Pharm. applicants

Desirable : Experience in surgical models of rodents

Duration of appointment : Initially for a period of one year

Candidates fulfilling the eligibility criteria may submit the application along with recent CV and other relevant documents to the Principal Investigator, Prof. Suhel Parvez, Head, Department of Medical Elementology & Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062 only by email (sparvez@jamiahamdard.ac.in).

Last date of receipt of applications is 19th April 2021.

Only short-listed candidates will be called for an interview.

Related Posts

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…

India’s drug body flags 90 unapproved FDC medicines, states told to take action

The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward